Cellectis SA (CLLS)
2.536
-0.02
(-0.94%)
USD |
NASDAQ |
May 01, 16:00
2.54
0.00 (0.00%)
After-Hours: 20:00
Cellectis Price to Book Value: 2.158 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 2.175 |
| April 29, 2024 | 2.175 |
| April 26, 2024 | 2.129 |
| April 25, 2024 | 2.115 |
| April 24, 2024 | 2.124 |
| April 23, 2024 | 2.226 |
| April 22, 2024 | 2.243 |
| April 19, 2024 | 2.166 |
| April 18, 2024 | 2.098 |
| April 17, 2024 | 2.090 |
| April 16, 2024 | 2.115 |
| April 15, 2024 | 2.217 |
| April 12, 2024 | 2.285 |
| April 11, 2024 | 2.379 |
| April 10, 2024 | 2.370 |
| April 09, 2024 | 2.336 |
| April 08, 2024 | 2.285 |
| April 05, 2024 | 2.277 |
| April 04, 2024 | 2.336 |
| April 03, 2024 | 2.370 |
| April 02, 2024 | 2.251 |
| April 01, 2024 | 2.158 |
| March 28, 2024 | 2.245 |
| March 27, 2024 | 2.262 |
| March 26, 2024 | 2.177 |
| Date | Value |
|---|---|
| March 25, 2024 | 2.186 |
| March 22, 2024 | 2.118 |
| March 21, 2024 | 2.143 |
| March 20, 2024 | 2.076 |
| March 19, 2024 | 2.042 |
| March 18, 2024 | 2.110 |
| March 15, 2024 | 2.152 |
| March 14, 2024 | 2.143 |
| March 13, 2024 | 2.169 |
| March 12, 2024 | 2.220 |
| March 11, 2024 | 2.059 |
| March 08, 2024 | 2.194 |
| March 07, 2024 | 2.126 |
| March 06, 2024 | 2.135 |
| March 05, 2024 | 2.101 |
| March 04, 2024 | 2.203 |
| March 01, 2024 | 2.245 |
| February 29, 2024 | 2.186 |
| February 28, 2024 | 2.155 |
| February 27, 2024 | 2.299 |
| February 26, 2024 | 2.299 |
| February 23, 2024 | 2.392 |
| February 22, 2024 | 2.460 |
| February 21, 2024 | 2.417 |
| February 20, 2024 | 2.307 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5691
Minimum
Jun 16 2022
5.012
Maximum
Jan 19 2021
1.835
Average
1.740
Median
Nov 25 2019
Price to Book Value Benchmarks
| DBV Technologies SA | 0.9125 |
| Genfit SA | 2.337 |
| Biophytis SA | -- |
| Edap TMS SA | 4.193 |
| Biodexa Pharmaceuticals Plc | 0.9860 |
Price to Book Value Related Metrics
| PS Ratio | 191.87 |
| Price | 2.536 |
| Earnings Yield | -70.08% |
| Market Cap | 181.82M |